Where Will Constellation Brands Stock Be in 3 Years?

Constellation Brands’ growth has stalled: beer (84% of revenue) slowed from double-digit to mid-single-digit growth, wine and spirits have contracted, and total revenue growth fell to 2% in FY2025 after a >40% share-price decline vs. a 70% S&P rally over three years. The company cites weaker consumption among younger and Hispanic cohorts, U.S. price increases, Mexican supply-chain constraints and tariffs on aluminum cans, and has right-sized lower-end wine and spirit portfolios—actions that trimmed revenue and left it more dependent on a cooling beer franchise; past impairments (notably Canopy Growth) turned GAAP results volatile. Near-term weakness is persistent—H1 FY2026 revenue fell ~10% YoY, management expects FY2026 organic revenue down 4%–6% (beer -2%–4%, wine/spirits -17%–20%), while analysts see a deeper drop but forecast stabilization in FY2027 and modest recovery in FY2028; at ~12x forward earnings with a ~2.9% yield the stock offers limited downside but also constrained upside until Constellation proves it can diversify its beer portfolio, navigate tariffs/supply issues and restore sustainable growth.

Analysis

Constellation Brands has seen material operational and share-price deterioration: the stock is down more than 40% over three years while the S&P 500 rose roughly 70%, and FY2025 revenue mix was 84% beer, 14% wine and 4% spirits. Reported three-year CAGR trends show beer revenue growth decelerating from 11% (FY2023) to 5% (FY2025), wine down -5% to -7%, spirits swinging from +6% to -11%, and total revenue growth slowing from 7% to 2% over the same period.

The deceleration stems from weaker consumption among younger and Hispanic cohorts, inflation-driven price increases, tariffs on aluminum cans (nearly 40% of beer shipments from Mexico), and Mexican supply-chain constraints including a cancelled brewery project; management’s strategy to sell lower-end wine and spirit brands has reduced those segments’ revenues and increased dependence on a cooling beer franchise. Constellation also suffered GAAP volatility from its Canopy Growth investment and recent impairment charges that drove a FY2025 net loss.

Near-term guidance and analyst expectations are cautious: H1 FY2026 revenue fell ~10% YoY, management expects FY2026 organic revenue down 4%–6% (beer -2%–4%, wine & spirits -17%–20%) while analysts project an 11% revenue decline, with stabilization forecast for FY2027 and modest recovery in FY2028. At ~12x forward adjusted earnings and a 2.9% forward yield the valuation caps downside but limits upside until Constellation demonstrably stabilizes execution, supply-chain/tariff exposure and end-market demand, so the stock is likely to trade sideways near term.

Key Decisions for Investors

• Avoid establishing a large, unhedged long position until management demonstrates sequential stabilization in beer volumes and material easing in wine/spirits organic declines,
• Consider a small, income-oriented allocation capped in size given the 2.9% forward yield and 12x forward earnings, while using position limits or protective hedges to offset execution and GAAP recovery risk,
• Monitor four catalysts before adding exposure: Mexican supply-chain resolution, tariff developments on cans, early signs of demand recovery among younger/Hispanic cohorts, and the company’s FY2027 guidance trajectory; consider buying into confirmed improvement or using options to express a conditional, lower-cost bullish view